Overview

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if surgery plus radiation therapy is more effective with or without chemotherapy for treating mouth cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery and radiation therapy with or without chemotherapy in treating patients with stage II, stage III, or stage IV mouth cancer.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
European Institute of Oncology
Treatments:
Cobalt
Fluorouracil
Criteria
DISEASE CHARACTERISTICS: Squamous cell carcinoma of the lower oral cavity eligible for
resection T2 (greater than 3 cm), T3, or T4, and N0-3 M0 (UICC staging system) No
requirement for postsurgical reconstruction that would impede further radiotherapy

PATIENT CHARACTERISTICS: Age: 70 and under Performance status: WHO 0 or 1 Hematopoietic:
WBC at least 3,500/mm3 Absolute neutrophil count at least 2,000/mm3 Platelet count at least
110,000/mm3 Hepatic: Not specified Renal: Creatinine no greater than 1.3 mg/dL Creatinine
clearance at least 50 mg/mL BUN no greater than 50 mg/dL Cardiovascular: No cardiopathy
Other: No significant internal disease No prior malignancy except basal cell carcinoma of
the skin No geographic barrier to treatment

PRIOR CONCURRENT THERAPY: No prior therapy